Skip to main content
. 2015 Aug 13;2015(8):CD010606. doi: 10.1002/14651858.CD010606.pub2

NCT01693367.

Trial name or title A Multi‐Center Randomized Controlled Pilot Study of Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation
Methods Interventional, randomised, efficacy study. Single blinded (participant)
Participants Inclusion criteria:
  • men and women

  • ≥ 21 years

  • closed or open distal femur fracture (AO 33 A1‐3, 33 C1‐3) including distal femur fractures above a total knee arthroplasty

  • ability to walk independently prior to injury

  • eligible for treatment with ORIF of the distal femur with a large fragment locking plate (Less Invasive Stabilisation System (LISS), LCP)

  • willing and able to comply with postoperative protocol and return for follow‐up

  • ability to understand the content of the participant information/informed consent form and participate in the clinical investigation

  • signed informed consent


Exclusion criteria:
  • additional ipsi‐ or contralateral lower extremity fracture

  • any type of implant at the ipsilateral proximal femur

  • pre‐existing malunion or non‐union of the ipsilateral lower extremity

  • segmental bone defect requiring bone grafting

  • > 4 weeks between injury and surgery

  • pathological fracture due to a disease other than osteoporosis (e.g. tumour, metastasis)

  • polytrauma

  • active malignancy

  • any not medically managed severe systemic disease

  • recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment

  • pregnancy or women planning to conceive within the study period

  • prisoner

  • participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Interventions DLS 5.0 (dynamic locking screws)
SLS (standard locking screw)
Outcomes
  • Timed up‐and‐go test (TUG) (time frame: 12 weeks ± 7 days, 6 months ± 30 days)

  • Quality of life (EuroQol‐5D) (time frame: preoperative, 6 weeks ± 7 days, 12 weeks ± 7 days, 6 months ± 30 days, 12 months up to 425 days after surgery)

  • Range of motion (time frame: 6 weeks ± 7 days, 12 weeks ± 7 days, 6 months ± 30 days, 12 months up to 425 days after surgery)

  • Full weight‐bearing status (time frame: weekly measurement at home). Assessment of the time point when the participant can bear the whole body weight on the affected leg at single‐leg‐stance for 3 seconds, can walk without walking aid has no intake of analgesics

  • Western Ontario and McMaster Universities Arthritis Index (WOMAC) (time frame: preoperative, 6 weeks ± 7 days, 12 weeks ± 7 days, 6 months ± 30 days, 12 months up to 425 days after surgery)

Starting date September 2102
Contact information Michael J Gardner, MD, Washington University School of Medicine
Notes